Covered recipient · General Payments record
MANUEL CALCAGNO CASASNOVAS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$850.53
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $612.79 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $206.17 | 10 |
| PFIZER INC. | $167.54 | 9 |
| Acerta Pharma LLC | $56.66 | 3 |
| Novo Nordisk AS | $50.76 | 3 |
| Lilly USA, LLC | $50.22 | 3 |
| Sumitomo Pharma America, Inc. | $29.35 | 2 |
| SANOFI-AVENTIS U.S. LLC | $19.78 | 1 |
| GlaxoSmithKline, LLC. | $18.58 | 1 |
| Exact Sciences Corporation | $13.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.03 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404443 | CMS |
| ABBVIE INC. | $28.03 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404445 | CMS |
| ABBVIE INC. | $13.63 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404447 | CMS |
| ABBVIE INC. | $12.74 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404449 | CMS |
| ABBVIE INC. | $13.60 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404451 | CMS |
| ABBVIE INC. | $28.97 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404453 | CMS |
| ABBVIE INC. | $5.75 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404455 | CMS |
| ABBVIE INC. | $25.43 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404457 | CMS |
| ABBVIE INC. | $28.30 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404459 | CMS |
| ABBVIE INC. | $31.69 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103404461 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.15 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105535928 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.40 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105459441 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.11 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104630212 | CMS |
| Exact Sciences Corporation | $13.73 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114605146 | CMS |
| GlaxoSmithKline, LLC. | $18.58 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116364573 | CMS |
| Lilly USA, LLC | $13.57 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135149464 | CMS |
| Lilly USA, LLC | $18.92 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135149462 | CMS |
| Lilly USA, LLC | $17.73 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135163097 | CMS |
| Novo Nordisk Inc | $18.64 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097201633 | CMS |
| Novo Nordisk Inc | $16.41 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096619626 | CMS |
| Novo Nordisk Inc | $15.71 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097432687 | CMS |
| PFIZER INC. | $21.96 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131105434 | CMS |
| PFIZER INC. | $18.32 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131265347 | CMS |
| PFIZER INC. | $16.04 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131121294 | CMS |
| PFIZER INC. | $16.59 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131261201 | CMS |
| PFIZER INC. | $16.77 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131390957 | CMS |
| PFIZER INC. | $15.90 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131479654 | CMS |
| PFIZER INC. | $22.37 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131761830 | CMS |
| PFIZER INC. | $14.84 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624446 | CMS |
| PFIZER INC. | $24.75 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131741268 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.78 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139576839 | CMS |
| Sumitomo Pharma America, Inc. | $13.41 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148834389 | CMS |
| Sumitomo Pharma America, Inc. | $15.94 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148834391 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.